CAMPAIGNERS hope powerful Spanish medicine licensing body AEMPS will act to prevent the commonly used analgesic metamizole being taken by certain expat groups because of potentially fatal side effects.
People of Anglo Saxon and Scandinavian heritage taking the pain-killer are at increased risk of developing agranulocytosis – a sudden plunge in numbers of disease-busting white blood cells – which can trigger a highly-dangerous sepsis.